share_log

Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector

Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector

醫療巨頭輝瑞、阿斯利康、賽諾菲注資超過20億美元以促進法國的醫療保健行業
Benzinga ·  05/13 11:36

Healthcare giants Pfizer Inc (NASDAQ:PFE) and AstraZeneca Plc (NASDAQ:AZN) have investments in France, collectively totaling around $1 billion, bolstering the country's healthcare sector.

醫療保健巨頭輝瑞公司(納斯達克股票代碼:PFE)和阿斯利康公司(納斯達克股票代碼:AZN)在法國的投資總額約爲10億美元,促進了該國的醫療保健行業。

Pfizer revealed plans to inject 500 million euros into expanding its research and development capabilities within France, while AstraZeneca disclosed a $388 million investment earmarked for its Dunkirk site.

輝瑞透露了注資5億歐元以擴大其在法國境內的研發能力的計劃,而阿斯利康則披露了專門用於敦刻爾克基地的3.88億美元投資。

French president Emmanuel Macron's upcoming 'Choose France' business summit receives a promising prelude with these substantial investment pledges. Set against the backdrop of economic revitalization efforts, these commitments align with Macron's agenda to attract foreign businesses and stimulate investment in France.

法國總統伊曼紐爾·馬克龍即將舉行的 “選擇法國” 商業峯會以這些巨額投資承諾迎來了充滿希望的前奏。在經濟振興努力的背景下,這些承諾符合馬克龍吸引外國企業和刺激在法國投資的議程。

Morgan Stanley (NYSE:MS) disclosed intentions to create 100 new positions in Paris, signaling a vote of confidence in the city's financial ecosystem, Reuters highlighted.

路透社強調,摩根士丹利(紐約證券交易所代碼:MS)透露了在巴黎設立100個新職位的意向,這表明了對該市金融生態系統的信任投票。

Additionally, notable investments from companies like German aviation firm Lilium underscore Paris' evolving role in the global business landscape.

此外,德國航空公司Lilium等公司的重大投資凸顯了巴黎在全球商業格局中不斷變化的作用。

Separately, Sanofi SA (NASDAQ:SNY) has an investment of more than €1 billion to create new bioproduction capacity at its sites in Vitry-sur-Seine (Val de Marne), Le Trait (Seine-Maritime) and Lyon Gerland (Rhône).

另外,賽諾菲公司(納斯達克股票代碼:SNY)已投資超過10億歐元,用於在塞納河畔維特里(馬恩河谷)、勒特雷特(濱海塞納省)和里昂熱爾蘭(羅納州)的基地建立新的生物生產能力。

This new investment will create more than 500 jobs and significantly strengthen France's ability to control the production of essential medicines from start to finish.

這項新投資將創造500多個就業機會,並顯著增強法國從頭到尾控制基本藥物生產的能力。

This plan brings to more than €3.5 billion, the amount committed by Sanofi since the COVID-19 pandemic in major projects to keep production of medicines and vaccines in France.

該計劃使法國的藥品和疫苗生產保持在法國的藥品和疫苗生產的重大項目中承諾的金額超過35億歐元。COVID-19

"Sanofi's contribution to France's trade balance amounted to more than €13 billion in 2023," the company said.

該公司表示:“賽諾菲在2023年對法國貿易平衡的貢獻超過130億歐元。”

Price Action: SNY shares are up 1.72% at $50.13, PFE stock is up 2% at $28.57, and AZN shares are up 0.23% at $77.36 at last check Monday.

價格走勢:週一最後一次查看時,紐約證券交易所股價上漲1.72%,至50.13美元,PFE股價上漲2%,至28.57美元,AZN股價上漲0.23%,至77.36美元。

Image by Nuno Lopes from Pixabay

圖片由努諾·洛佩斯在 Pixabay 上拍攝

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論